Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Companies 1/25
Result 450 decisions over 120 months
Reset filters
Minimum amount ? Share of their own holding ?
What the chief executive holds ?
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
15 Mar 2023
CVP, TMTT
Sold, plan not stated
4,435
$343.56K
19.0%
14 Mar 2023
Chairman & CEO
Sold, plan not stated
19,875
$1.54M
24.6%
8 Mar 2023
CVP,Strategy/Corp Development
Sold, plan not stated
6,725
$517.56K
9.7%
8 Mar 2023
CVP, EMEACLA and JAPAC
Sold, plan not stated
6,640
$511.00K
3.8%
16 Feb 2023
Director
Sold, plan not stated
9,671
$742.94K
26.0%
15 Feb 2023
CVP, TMTT
Sold, plan not stated
4,000
$304.04K
17.5%
14 Feb 2023
Chairman & CEO
Sold, plan not stated
19,875
$1.53M
11.2%
6 Feb 2023
CVP,Strategy/Corp Development
Sold, plan not stated
6,725
$543.04K
9.7%
17 Jan 2023
CVP, TMTT
Sold, plan not stated
4,000
$312.00K
17.5%
13 Jan 2023
Chairman & CEO
Sold, plan not stated
19,875
$1.55M
11.2%
9 Jan 2023
CVP,Strategy/Corp Development
Sold, plan not stated
6,725
$521.19K
9.7%
15 Dec 2022
CVP, Surgical Structural Heart
Sold, plan not stated
4,000
$299.20K
17.5%
14 Dec 2022
Chairman & CEO
Sold, plan not stated
19,875
$1.52M
11.2%
13 Dec 2022
CVP, TAVR
Sold, plan not stated
7,236
$557.02K
3.5%
12 Dec 2022
CVP,Strategy/Corp Development
Sold, plan not stated
6,725
$499.80K
9.7%
15 Nov 2022
CVP, Surgical Structural Heart
Sold, plan not stated
4,000
$296.72K
17.5%
14 Nov 2022
Chairman & CEO
Sold, plan not stated
19,875
$1.47M
11.2%
8 Nov 2022
CVP, TAVR
Sold, plan not stated
7,242
$496.06K
3.5%
8 Nov 2022
CVP,Strategy/Corp Development
Sold, plan not stated
6,725
$460.39K
9.7%
14 Oct 2022
Chairman & CEO
Sold, plan not stated
19,875
$1.65M
11.2%
14 Oct 2022
CVP, Surgical Structural Heart
Sold, plan not stated
4,000
$339.08K
17.5%
11 Oct 2022
CVP, TAVR
Sold, plan not stated
7,242
$594.71K
3.5%
10 Oct 2022
CVP,Strategy/Corp Development
Sold, plan not stated
6,725
$571.63K
9.7%
22 Sep 2022
Chairman & CEO
Sold, plan not stated
19,875
$1.67M
11.2%
8 Sep 2022
CVP,Strategy/Corp Development
Sold, plan not stated
6,725
$611.57K
9.7%
6 Sep 2022
CVP, TAVR
Sold, plan not stated
7,242
$644.54K
3.5%
15 Aug 2022
Chairman & CEO
Sold, plan not stated
19,875
$2.08M
11.2%
9 Aug 2022
CVP, TAVR
Sold, plan not stated
7,242
$758.30K
3.5%
9 Aug 2022
CVP,Strategy/Corp Development
Sold, plan not stated
6,725
$706.19K
9.7%
5 Aug 2022
CVP, TMTT
Sold, plan not stated
4,811
$498.71K
18.5%
2 Aug 2022
CVP, Surgical Structural Heart
Sold, plan not stated
1,000
$102.49K
5.0%
14 Jul 2022
Chairman & CEO
Sold, plan not stated
19,875
$1.91M
10.6%
8 Jul 2022
CVP,Strategy/Corp Development
Sold, plan not stated
6,725
$656.36K
9.7%
8 Jul 2022
CVP, Japan & Intercontinental
Sold, plan not stated
3,675
$358.68K
3.6%
5 Jul 2022
CVP, TAVR
Sold, plan not stated
7,242
$694.49K
3.5%
14 Jun 2022
Chairman & CEO
Sold, plan not stated
19,875
$1.73M
11.2%
14 Jun 2022
CVP, TMTT
Sold, plan not stated
4,809
$421.99K
15.6%
14 Jun 2022
CVP, Japan & Intercontinental
Sold, plan not stated
3,675
$322.48K
3.6%
13 Jun 2022
CVP,Strategy/Corp Development
Sold, plan not stated
6,725
$605.41K
9.7%
1 Jun 2022
CVP, TAVR
Sold, plan not stated
7,242
$728.05K
3.5%
31 May 2022
CVP, TMTT
Sold, plan not stated
9,000
$907.49K
22.6%
26 May 2022
CVP, Surgical Structural Heart
Sold, plan not stated
1,000
$98.31K
4.8%
24 May 2022
CVP, TMTT
Sold, plan not stated
4,809
$459.36K
10.8%
10 May 2022
Chairman & CEO
Sold, plan not stated
32,550
$3.09M
17.1%
10 May 2022
CVP, TAVR
Sold, plan not stated
7,242
$696.18K
3.4%
9 May 2022
CVP, EMEA, Canada, Latin Amer
Sold, plan not stated
11,560
$1.14M
6.6%
9 May 2022
CVP,Strategy/Corp Development
Sold, plan not stated
6,725
$663.82K
9.5%
9 May 2022
CVP, Japan & Intercontinental
Sold, plan not stated
3,675
$362.76K
3.5%
4 May 2022
CVP, Critical Care
Sold, plan not stated
23,400
$2.45M
43.1%
29 Apr 2022
Chairman & CEO
Sold, plan not stated
32,550
$3.51M
26.2%
Showing 1–50 of 450. Page 1 of 9 Older →